UPC

Universe Pharmaceuticals (UPC) P/E Ratio
P/E Ratio as of Oct 26, 2026: -0.84
Average-1.21
Median-1.22
Minimum-1.39
Maximum-0.8400
-0.84
0.54 (39.13%)past month
The P/E ratio for Universe Pharmaceuticals (UPC) is -0.84 as of Oct 26, 2026. This represents a increase of 52.73% compared to its 12-month average P/E ratio of -0.55. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Universe Pharmaceuticals P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Universe Pharmaceuticals’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Universe Pharmaceuticals to industry peers.
Universe Pharmaceuticals P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Universe Pharmaceuticals’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Universe Pharmaceuticals to industry peers.
Universe Pharmaceuticals (UPC) P/E Ratio Insights
See Universe Pharmaceuticals’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Universe Pharmaceuticals (UPC)
Order type
Buy in
Order amount
Est. shares
0 shares
Universe Pharmaceuticals (UPC) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Oct 1, 2026 | $4.31 | -1.25 |
| Sep 1, 2026 | $4.27 | -1.24 |
| Aug 3, 2026 | $6.48 | -1.88 |
| Jul 1, 2026 | $5.56 | -0.55 |
| Jun 1, 2026 | $3.37 | -0.33 |
| May 1, 2026 | $3.21 | -0.32 |
| Apr 1, 2026 | $2.73 | -0.27 |
| Mar 2, 2026 | $2.72 | -0.27 |
| Feb 2, 2026 | $4.41 | -0.44 |
| Jan 2, 2026 | $4.16 | 0.00 |
Universe Pharmaceuticals (UPC) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2026 | -0.84 | 0.00% |
| 2025 | 0.00 | -100.00% |
| 2024 | -4.79 | -99.32% |
| 2023 | -709.37 | -67.25% |
| 2022 | -2165.89 | -214.91% |
| 2021 | 1884.91 | — |
FAQs About Universe Pharmaceuticals (UPC) P/E ratio
The latest P/E ratio of Universe Pharmaceuticals (UPC) is -0.84, as of Oct 26, 2026. This is calculated based on its current stock price and earnings per share (EPS).
Universe Pharmaceuticals’s last 12-month average P/E ratio is -0.55, compared to its current P/E ratio of -0.84. This reflects a increase of 52.73%.
Universe Pharmaceuticals’s current P/E ratio of -0.84 is higher than its last 12-month average P/E of -0.55. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Universe Pharmaceuticals’s average P/E ratio over the last 3 years is -132.65. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Universe Pharmaceuticals’s average P/E ratio over the last 5 years is 62.31. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.
Universe Pharmaceuticals (UPC) P/E Ratio Insights
See Universe Pharmaceuticals’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Universe Pharmaceuticals (UPC)
Order type
Buy in
Order amount
Est. shares
0 shares
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.